Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (211-220 of 662) with videos related to

Pageof 67
Sort By:
Leukemia|January 26, 2019
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complexLuisa Schmidt, Elizabeth Heyes, Lisa Scheiblecker, et al.
The Journal of Allergy and Clinical Immunology|March 18, 2011
A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreSKatarzyna Niespodziana, Margarete Focke-Tejkl, Birgit Linhart, et al.
The American Journal of Surgical Pathology|September 17, 2004
CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimensKarl Sotlar, Hans-Peter Horny, Ingrid Simonitsch, et al.
Leukemia & Lymphoma|October 6, 2007
Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2Anja Vales, Rudin Kondo, Karl J Aichberger, et al.
British Journal of Haematology|August 22, 2003
Diagnosis and treatment of systemic mastocytosis: state of the artPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
European Journal of Haematology|June 11, 2005
An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of AML in the terminal phaseKaroline Sonneck, Christine Mannhalter, Maria-Theresa Krauth, et al.
Seminars in Immunopathology|May 30, 2021
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexityPeter Valent, Lina Degenfeld-Schonburg, Irina Sadovnik, et al.
The Journal of Allergy and Clinical Immunology|November 5, 2013
Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5Margarete Focke-Tejkl, Raffaela Campana, Renate Reininger, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2015
Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosisTim Wiechers, Anja Rabenhorst, Tina Schick, et al.
Best Practice & Research. Clinical Haematology|November 30, 2010
Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cellsPeter Valent, Sabine Cerny-Reiterer, Harald Herrmann, et al.
Pageof 67

Showing results (211-220 of 662) with videos related to

Sort By:
Pageof 67
Leukemia|January 26, 2019
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complexLuisa Schmidt, Elizabeth Heyes, Lisa Scheiblecker, et al.
The Journal of Allergy and Clinical Immunology|March 18, 2011
A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreSKatarzyna Niespodziana, Margarete Focke-Tejkl, Birgit Linhart, et al.
The American Journal of Surgical Pathology|September 17, 2004
CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimensKarl Sotlar, Hans-Peter Horny, Ingrid Simonitsch, et al.
Leukemia & Lymphoma|October 6, 2007
Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2Anja Vales, Rudin Kondo, Karl J Aichberger, et al.
British Journal of Haematology|August 22, 2003
Diagnosis and treatment of systemic mastocytosis: state of the artPeter Valent, Cem Akin, Wolfgang R Sperr, et al.
European Journal of Haematology|June 11, 2005
An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of AML in the terminal phaseKaroline Sonneck, Christine Mannhalter, Maria-Theresa Krauth, et al.
Seminars in Immunopathology|May 30, 2021
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexityPeter Valent, Lina Degenfeld-Schonburg, Irina Sadovnik, et al.
The Journal of Allergy and Clinical Immunology|November 5, 2013
Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5Margarete Focke-Tejkl, Raffaela Campana, Renate Reininger, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2015
Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosisTim Wiechers, Anja Rabenhorst, Tina Schick, et al.
Best Practice & Research. Clinical Haematology|November 30, 2010
Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cellsPeter Valent, Sabine Cerny-Reiterer, Harald Herrmann, et al.
Pageof 67